The intra-monocyte pharmacokinetics of imiglucerase suggests a possible personalization of enzyme replacement therapy in patients with GD1

Autor:	Marc G. Berger, Juliette Berger, Marie Vigan, Bruno Pereira, Roseline Froissart, Nadia Belmatoug, Florence Dalbies, Agathe Masseau, Christian Rose, Christine Serratrice, Yves-Maris Pers, Ivan Bertschanski, Monia Bengherbia, Céline Bourgne, Alexandre Janel, Catherine Caillaud, Magali Pettazzoni, Amina Berrahal, Jérôme Stirnemann, France Mentré
Rok vydání:	2018
Předmět:	Imiglucerase business.industry Endocrinology Diabetes and Metabolism Monocyte Enzyme replacement therapy Pharmacology Biochemistry Personalization Endocrinology medicine.anatomical_structure Pharmacokinetics Genetics medicine In patient business Molecular Biology medicine.drug
Zdroj:	Molecular Genetics and Metabolism. 123:S23-S24
ISSN:	1096-7192
DOI:	10.1016/j.ymgme.2017.12.035
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1d08cd36e6d419cb019aa6e784f7966d https://doi.org/10.1016/j.ymgme.2017.12.035 Zobrazit plný text záznamu Full Text from ScienceDirect